share_log

Appili Therapeutics Inc. (TSE:APL) Forecasted to Post FY2023 Earnings of ($0.10) Per Share

Defense World ·  Jul 18, 2022 14:31

Appili Therapeutics Inc. (TSE:APL – Get Rating) – Zacks Small Cap issued their FY2023 earnings estimates for Appili Therapeutics in a note issued to investors on Thursday, July 14th. Zacks Small Cap analyst D. Bautz forecasts that the company will earn ($0.10) per share for the year. Zacks Small Cap also issued estimates for Appili Therapeutics' FY2024 earnings at ($0.07) EPS and FY2025 earnings at ($0.06) EPS.

Appili Therapeutics Stock Performance

Featured Articles

  • Financial services firm Block stock has fallen (-59%) in 2022
  • Hold Pfizer Today With Catalysts for Further Growth Tomorrow
  • NVIDIA Stock is a Winding Up for a Record Setting Second Half
  • Johnson & Johnson Continues to Prove its Value in a Volatile Year
  • MarketBeat: Week in Review 7/11 – 7/15

Receive News & Ratings for Appili Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Appili Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment